Literature DB >> 21496473

Economic burden of rotavirus disease in children under 5 years in Kazakhstan.

Renat Latipov1, Aynagul Kuatbaeva, Olga Kristiansen, Saltanat Aubakirova, Ulbosin Akhanaeva, Ivar Sønbø Kristiansen, Elmira Flem.   

Abstract

BACKGROUND: We aimed to estimate the societal costs of rotavirus cases among children less than 5 years in Kazakhstan, an upper-middle income country in Central Asia.
METHODS: Data on medical, non-medical and indirect costs were collected for 190 patients less than 5 years, hospitalized with severe diarrhea in 2009 in two pediatric hospitals. Data on resource use for moderate and mild diarrhea cases were obtained from published sources. A probabilistic sensitivity analysis was performed to explore uncertainty in cost estimates.
RESULTS: Approximately 4,000 severe, 30,700 moderate, and 122,900 mild rotavirus cases were estimated annually in children <5 years old. The mean societal cost of a severe, moderate and mild rotavirus case was estimated at US$ 454, 82, and 21, respectively. The total annual cost of rotavirus disease was $37.53 million or on average $107.36 for a child under 5 years old in Kazakhstan. Ninety-four percent of total costs (35.13 million) are indirect costs (productivity losses) from fatal cases and parents' job absenteeism, while direct medical costs account for 2.04 million (5.4%), and direct non-medical for 0.46 million (1.2%).
CONCLUSIONS: Rotavirus-associated diarrhea represents a significant economic burden in Kazakhstan, largely due to indirect costs. The costs of rotavirus infections should be considered when planning further preventive actions, including the introduction of rotavirus vaccination.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21496473     DOI: 10.1016/j.vaccine.2011.03.019

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Household Costs of Diarrhea by Etiology in 7 Countries, The Global Enterics Mulitcenter Study (GEMS).

Authors:  Marita Zimmermann; Karen Kotloff; Dilruba Nasrin; Anna Roose; Myron M Levine; Richard Rheingans; Tamar Farag; Damian Walker; Clint Pecenka
Journal:  Open Forum Infect Dis       Date:  2019-04-03       Impact factor: 3.835

2.  Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

Authors:  Birgitte Freiesleben de Blasio; Elmira Flem; Renat Latipov; Ajnagul Kuatbaeva; Ivar Sønbø Kristiansen
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.